Finasteride Tablet, Film Coated
Product Images NDC 63187-265

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 63187-265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-265-30 (Finasteride 30 Label)

Finasteride 5 mg film-coated tablets packaging label by Proficient Rx LP. The label indicates a 30-tablet bottle, each tablet containing 5 mg finasteride. Tablets are described as blue, 7 mm, round, biconvex, film-coated, marked 'F5' on one side and plain on the other. The label includes usage warnings, manufacturer details (Intas Pharmaceuticals Limited, India), storage instructions, and regulatory codes.*

FDA Label Image

Structure (Finasteride Fig 1)

Chemical structure of finasteride, the active ingredient in Finasteride film-coated tablets. The diagram illustrates the molecular structure with labeled atoms and bonds.*

FDA Label Image

Image Of Figure 1 (Finasteride Fig 2)

A line graph showing mean change from baseline with standard error over four years comparing Finasteride and Placebo groups. The x-axis represents time points from baseline through year 4, and the y-axis shows mean change values ranging from 0 to -6. Data points with sample sizes are indicated for both groups throughout the study period.*

FDA Label Image

Image Of Figure 2 (Finasteride Fig 3)

A line graph comparing the cumulative percent of patients over time (in months) between Finasteride and placebo groups. The x-axis represents observation time up to 48 months, and the y-axis shows the percent of patients up to 15%. Data includes the number of events and patients at risk per year for both placebo and Finasteride groups.*

FDA Label Image

Image Of Figure 3 (Finasteride Fig 4)

A line graph depicting mean percent changes from baseline with standard error in two groups over four years. The x-axis represents time points from Baseline to Year 4, the y-axis shows percent change from -20 to +20. One line shows increasing positive change, the other shows decreasing negative change. The groups are labeled as Placebo and Finasteride with respective sample sizes noted.*

FDA Label Image

Image Of Figure 4 (Finasteride Fig 5)

A line chart showing the percent of events over 5.5 years from randomization comparing four groups: Placebo, Finasteride, Doxazosin, and Combination. The y-axis presents the percent with event, and the x-axis shows years from randomization. Each group has a distinct line indicating changes in event rates over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.